Member Info for Nextlink

Since late October we have seen a significant recovery to July 2018 Highs.
We are now at levels not seen in seven years.
It is looking like 2020 will be a great year for Aortech.

Sad news for the employees at Geocurve if correct., especially at
this time of year.
If that side of the operation was to cease, it would immediately
reduce outgoings significantly.
It has been clear that Gyrometrics is the potential diamond,
with few if any competitors.
Geocurve by contrast is in a crowded market.

Nice to see the Company giving a comprehensive update on
the significant investments.
A little frustrating to see everyone of them still at the jam
tomorrow stage.
Just one getting past that would be nice.

Thank you.
Directors have to very guarded in what they say to individual investors.
It is an opaque remark which can just read we intend to reverse, which has been
the case for over three years.
I hope your interpretation of that remark is correct, it would be great news.

They first announced the possibility of a US listing in January 2017
or an investment offer from a private partner.
However I would think Leap is now a far more valuable asset now.
I doubt a Nasdaq listing would have been possible three years ago, as
you say, it may be now.

Apart from a Boardroom bust up or shareholder action 99% of AGM's are
a flat "All resolutions were passed"
So like Ecuagold I am not expecting anything from the AGM.
Earlier this year we were all excited when Highway was restored to a ready to go shell
and then nothing.
What puzzles me is why most are anticipating the long awaited reverse takeover.
The news could come at any time, probably when least expected and we have forgotten we
are shareholders.
Has one of our posters heard a whisper or is it just the wish the AGM will reveal all.

Given the poor results from Geocurve the sp is close to it's all time low.
Directors have continued to support this Company with cash injections.
The trials and negotiations with major Companies have been under way for some time.
In recent days share selling has ceased, although it appears there is an overhang.
It may be significant in number of shares, but given the current sp, in terms of cash
value it probably wouldn't take much to eliminate.
It has been a long wait for any significant Contract for Gyrometrics.
No doubt many have given up and sold up.
One will arrive without warning.

They are a private Company and have no requirement to disclose.
https://www.linkassetservices.com/who-we-are/our-story

I have concluded that it is a paper exercise and although Woodford has gone,
whoever manages the holding still needs to find a buyer at some point.
If it was an unrelated fund they would have bought the shares and therefore
they would have been traded.
It wasn't the good news I thought initially, but it isn't bad news either.

Wish I had noticed that.
May only be related to his dismissal and we still have the 32% overhang.
Hoping it is a transfer to a fund with no Woodford connection.
If it is the former, why not notify a complete transfer.

Two days ago Woodford had managed to sell half his holding.
The sp has held up well, given the sale of such a large holding.
Yes it has halved, but given the scale of selling not bad.
Maybe we will get further notices indicating institutional buyers.

From elsewhere
WPCT owns 4.4m shares (13.7%) and Equity Income has 6.1m (19.3%)

This recent news from a Company, which may have an inferior product, in terms of quality and cost, is
going to put Aortech in the limelight.
I believe there only Aortech and Foldax in the running and the market is large enough for others.
From our latest update we know further news is due next month.
https://www.biospace.com/article/releases/foldax-inc-successfully-completes-first-in-human-use-of-next-generation-tria-polymer-heart-valve-for-the-treatment-of-aortic-valve-disease/

We can anticipate good news of the steady progress, low cash burn variety.
However something dramatic cannot be ruled out.
I am not suggesting an implant of a heart valve, that is some way off yet.

No indication there is any shorting currently. https://www.shorttracker.co.uk/companies/
As I understand it, difficult to short small market cap companies.
Neil Woodford through his funds Woodford Investment Management Limited holds almost 33%.
Given his catastrophic investment strategy he is a forced seller of any liquid investment he holds.
It is possible he is now reducing his holding in Reneuron, despite havng paid more than 3 times it's
current value.

It is also not bad news.
It has relevance so they were obliged to report the award to one
of their advisers.

Over the last three years a number of shells have reversed.
So it cannot be Brexit.
Lets hope they do a deal in our lifetimes.

This is a company with no income and basically on life support.
I would like the conversion to be 10 pence rather than 5 pence.
You could argue that if any one of us had £100k behind the sofa we could demand to
invest on the same terms, with all the attached risks.
I don't believe this loan note pricing will have any connection with a relisting price.
That will be purely down to the quality of any deal.

Earlier today quoted 14.25 pence to buy.
Took the dog for a walk and two hours later bought at 13.4 pence.
Is liquidity improving and is the spread narrowing, hoping it is.

MM's keen to show it negative, widening the spread late in the day
on no trades.

As I understand it the concert Party Hold 229,829,175 ordinary shares representing 63.62%* of the enlarged share capital.
So as the threshold is 30% they must have a waiver.